{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:18:51Z","timestamp":1777933131500,"version":"3.51.4"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1018","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Vitiligo is a common disease that causes a great degree of psychological distress. In its classical forms it is easily recognised and diagnosed. This review provides an evidence based outline of the management of vitiligo, particularly with the non-specialist in mind. Treatments for vitiligo are generally unsatisfactory. The initial approach to a patient who is thought to have vitiligo is to make a definite diagnosis, offer psychological support, and suggest supportive treatments such as the use of camouflage cosmetics and sunscreens, or in some cases after discussion the option of no treatment. Active therapies open to the non-specialist, after an explanation of potential side effects, include the topical use of potent or highly potent steroids or calcineurin inhibitors for a defined period of time (usually 2\u2005months), following which an assessment is made to establish whether or not there has been a response. Patients whose condition is difficult to diagnose, unresponsive to straightforward treatments, or is causing psychological distress, are usually referred to a dermatologist. Specialist dermatology units have at their disposal phototherapy, either narrow band ultraviolet B or in some cases photochemotherapy, which is the most effective treatment presently available and can be considered for symmetrical types of vitiligo. Depigmenting treatments and possibly surgical approaches may be appropriate for vitiligo in selected cases. There is no evidence that presently available systemic treatments are helpful and safe in vitiligo. There is a need for further research into the causes of vitiligo, and into discovering better treatments.<\/jats:p>","DOI":"10.1136\/pgmj.2009.093278","type":"journal-article","created":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T14:33:36Z","timestamp":1281710016000},"page":"466-471","source":"Crossref","is-referenced-by-count":37,"title":["Vitiligo: concise evidence based guidelines on diagnosis and management"],"prefix":"10.1093","volume":"86","author":[{"given":"David J","family":"Gawkrodger","sequence":"first","affiliation":[{"name":"British Association of Dermatologists , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony D","family":"Ormerod","sequence":"additional","affiliation":[{"name":"Therapy, Guidelines and Audit subcommittee of the British Association of Dermatologists , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Shaw","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Paediatric Dermatology, Bristol Royal Infirmary , Bristol , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inma","family":"Mauri-Sole","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Paediatric Dermatology, Bristol Royal Infirmary , Bristol , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxine E","family":"Whitton","sequence":"additional","affiliation":[{"name":"The Vitiligo Society , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Jane","family":"Watts","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Whipps Cross Hospital , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex V","family":"Anstey","sequence":"additional","affiliation":[{"name":"British Photodermatology Group, British Association of Dermatologists , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Ingham","sequence":"additional","affiliation":[{"name":"Clinical Standards Department, Royal College of Physicians of London , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine","family":"Young","sequence":"additional","affiliation":[{"name":"Clinical Standards Department, Royal College of Physicians of London , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,8,13]]},"reference":[{"key":"2023041909012649300_b1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0733-8635(05)70416-2","article-title":"Recent investigations on vitiligo vulgaris","volume":"15","author":"Nordlund","year":"1997","journal-title":"Dermatologic Clinics"},{"key":"2023041909012649300_b2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2230.2005.01779.x","article-title":"Vitiligo presentation in adults","volume":"30","author":"Mason","year":"2005","journal-title":"Clin Exper Dermatol"},{"key":"2023041909012649300_b3","first-page":"981","article-title":"Genetic epidemiology of vitiligo: Multilocus recessivity cross-validated","volume":"55","author":"Nath","year":"1994","journal-title":"Am J Hum Genet"},{"key":"2023041909012649300_b4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","article-title":"Guideline for the diagnosis and management of vitiligo","volume":"159","author":"Gawkrodger","year":"2008","journal-title":"Br J Dermatol"},{"key":"2023041909012649300_b5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003263.pub4","article-title":"Interventions for vitiligo","author":"Whitton","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"2023041909012649300_b6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-4632.2004.02059.x","article-title":"What patients with vitiligo believe about their condition","volume":"43","author":"Firooz","year":"2004","journal-title":"Int J Dermatol"},{"key":"2023041909012649300_b7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1468-3083.2002.00590.x","article-title":"Psychiatric morbidity in vitiligo: prevalence and correlates in India","volume":"16","author":"Mattoo","year":"2002","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"2023041909012649300_b8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000084751","article-title":"Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage","volume":"210","author":"Ongenae","year":"2005","journal-title":"Dermatology"},{"issue":"Pt 3","key":"2023041909012649300_b9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1348\/000711299160077","article-title":"Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy","volume":"72","author":"Papadopoulos","year":"1999","journal-title":"Br J Med Psychol"},{"key":"2023041909012649300_b10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1037\/1040-3590.15.4.532","article-title":"Measuring adjustment to chronic skin disorders: validation of a self-report measure","volume":"15","author":"Stangier","year":"2003","journal-title":"Psychological Assessment"},{"key":"2023041909012649300_b11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/eje.0.1430639","article-title":"Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT)","volume":"143","author":"Bjoro","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"2023041909012649300_b12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2133.1977.tb05188.x","article-title":"A double-blind trial of 0-05% clobetasol proprionate in the treatment of vitiligo","volume":"96","author":"Clayton","year":"1977","journal-title":"Br J Dermatol"},{"key":"2023041909012649300_b13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2133.1974.tb13086.x","article-title":"Treatment of vitiligo with 0-1 per cent betamethasone 17-valerate in isopropyl alcohol\u2013a double-blind trial","volume":"91","author":"Kandil","year":"1974","journal-title":"Br J Dermatol"},{"key":"2023041909012649300_b14","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archderm.135.9.1061","article-title":"Left-right comparison study of the combination of fluticasone propionate and UV-A vs either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo","volume":"135","author":"Westerhof","year":"1999","journal-title":"Arch Dermatol"},{"key":"2023041909012649300_b15","first-page":"88","article-title":"Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo","volume":"15","author":"Coskun","year":"2005","journal-title":"Eur J Dermatol"},{"key":"2023041909012649300_b16","first-page":"55","article-title":"Topical pimecrolimus in the treatment of vitiligo","volume":"17","author":"Boone","year":"2007","journal-title":"Eur J Dermatol"},{"key":"2023041909012649300_b17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"2023041909012649300_b18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2133.1977.tb14275.x","article-title":"Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature","volume":"97","author":"Mosher","year":"1977","journal-title":"Br J Dermatol"},{"key":"2023041909012649300_b19","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1067\/mjd.2001.113475","article-title":"Oral dexamethasone pulse treatment for vitiligo","volume":"44","author":"Radakovic","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"2023041909012649300_b20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09546630600791442","article-title":"The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients","volume":"17","author":"Radmanesh","year":"2006","journal-title":"J Dermatol Treat"},{"key":"2023041909012649300_b21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archderm.143.5.578","article-title":"Randomised double-blind trial of treatment of vitiligo. Efficacy of Psoralen-UVA vs. narrowband-UVB therapy","volume":"143","author":"Yones","year":"2007","journal-title":"Arch Dermatol"},{"key":"2023041909012649300_b22","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archderm.1997.03890480045006","article-title":"Treatment of vitiligo with UV-B radiation vs topical Psoralen plus UVA","volume":"133","author":"Westerhof","year":"1997","journal-title":"Arch Dermatol"},{"key":"2023041909012649300_b23","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1001\/archderm.134.12.1543","article-title":"A systematic review of autologous transplantation methods in vitiligo","volume":"134","author":"Njoo","year":"1998","journal-title":"Arch Dermatol"},{"key":"2023041909012649300_b24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000246690","article-title":"Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients","volume":"190","author":"Schallreuter","year":"1995","journal-title":"Dermatology"},{"key":"2023041909012649300_b25","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-2133.2009.09252.x","article-title":"A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo","volume":"161","author":"Bakis-Petsoglou","year":"2009","journal-title":"Br J Dermatol"},{"key":"2023041909012649300_b26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/135485099106261","article-title":"Psychological factors in cutaneous disease; an overview of research","volume":"4","author":"Papadopoulos","year":"1999","journal-title":"Psychol Health Med"},{"key":"2023041909012649300_b27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1348\/135910702169457","article-title":"Living with vitiligo: dealing with difference","volume":"7","author":"Thomson","year":"2002","journal-title":"Br J Health Psychol"},{"key":"2023041909012649300_b28","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/jid.2009.347","article-title":"Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8","volume":"130","author":"Birlea","year":"2010","journal-title":"J Invest Dermatol"},{"key":"2023041909012649300_b29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/jid.2009.207","article-title":"Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library","volume":"130","author":"Waterman","year":"2010","journal-title":"J Invest Dermatol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/86\/1018\/466\/50020018\/postgradmedj-86-466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/86\/1018\/466\/50020018\/postgradmedj-86-466.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T09:26:15Z","timestamp":1681896375000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/86\/1018\/466\/7019329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,1]]},"references-count":29,"journal-issue":{"issue":"1018","published-online":{"date-parts":[[2010,8,13]]},"published-print":{"date-parts":[[2010,8,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2009.093278","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,8]]},"published":{"date-parts":[[2010,8,1]]}}}